Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:KOSNYSE:SQZ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKOSKosmos Energy$1.71-0.6%$2.17$1.39▼$6.33$822.00M1.948.17 million shs6.79 million shsSQZSQZ Biotechnologies$0.04+42.9%$0.03$0.25▼$3.56$1.18M2.34455,220 shs14,971 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKOSKosmos Energy-0.87%-5.11%-27.08%-50.29%-71.24%SQZSQZ Biotechnologies0.00%0.00%0.00%-6.67%-39.78%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKOSKosmos Energy4.1735 of 5 stars3.32.01.70.04.12.51.9SQZSQZ BiotechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKOSKosmos Energy 2.50Moderate Buy$5.27207.99% UpsideSQZSQZ Biotechnologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest GKP, SEPL, KOS, and SQZ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2025KOSKosmos EnergyThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$5.00 ➝ $4.003/4/2025KOSKosmos EnergyBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKOSKosmos Energy$1.68B0.49$0.92 per share1.85$2.24 per share0.76SQZSQZ Biotechnologies$18.16M0.06N/AN/A$1.94 per share0.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKOSKosmos Energy$213.52M$0.393.895.705.2412.21%31.08%6.53%5/6/2025 (Estimated)SQZSQZ Biotechnologies-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/ALatest GKP, SEPL, KOS, and SQZ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025KOSKosmos Energy-$0.0833N/AN/AN/A$338.23 millionN/A2/24/2025Q4 2024KOSKosmos Energy$0.01-$0.01-$0.02-$0.01$387.60 million$397.66 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKOSKosmos Energy$0.1810.58%N/A46.41%N/ASQZSQZ BiotechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKOSKosmos Energy2.250.750.47SQZSQZ BiotechnologiesN/A3.503.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKOSKosmos Energy95.33%SQZSQZ Biotechnologies38.51%Insider OwnershipCompanyInsider OwnershipKOSKosmos Energy2.02%SQZSQZ Biotechnologies16.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableKOSKosmos Energy240477.91 million462.36 millionOptionableSQZSQZ Biotechnologies1,62029.49 million24.77 millionNot OptionableGKP, SEPL, KOS, and SQZ HeadlinesRecent News About These CompaniesSerica Energy shares drop as Triton suspended until mid-MarchFebruary 18, 2025 | proactiveinvestors.co.ukSerica Energy says 2025 outlook is ‘promising'January 21, 2025 | proactiveinvestors.co.ukSerica Energy expects to remedy “clearly disappointing†recent production performanceJanuary 7, 2025 | proactiveinvestors.co.ukSQZ Biotechnologies Co Ordinary SharesDecember 23, 2024 | morningstar.comPortal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA VenturesDecember 20, 2024 | finance.yahoo.comGlobal Short-Acting Insulin Market is Expected to Cross ~USD 9 Billion by 2030 | DelveInsightSeptember 5, 2024 | prnewswire.co.ukSTEMCELL Launches Novel Cell-Engineering CellPore™ Transfection SystemAugust 1, 2024 | valdostadailytimes.comWhat is the price tag to keep the biotech engine humming in Massachusetts?July 23, 2024 | msn.comSQZ Biotechnologies Company (SQZB)May 22, 2024 | finance.yahoo.comSqz Bio (SQZB) Earnings Dates & ReportsMay 8, 2024 | investing.comVC funding update: who raised money in March?April 1, 2024 | bizjournals.comSQZ, Portal founder Armon Sharei on starting over in biotechMarch 26, 2024 | biopharmadive.comPortal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VCMarch 19, 2024 | finance.yahoo.comSQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to StemcellMarch 1, 2024 | fiercebiotech.comRx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and moreFebruary 16, 2024 | mmm-online.comSQZB SQZ Biotechnologies CompanyDecember 28, 2023 | seekingalpha.comSQZ Biotechnologies Co Ordinary Shares SQZBDecember 12, 2023 | morningstar.comSQZ founder Armon Sharei opens Portal to to simplify intracellular deliveryDecember 12, 2023 | fiercebiotech.com'Medicine at a bigger scale': FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing siteNovember 11, 2023 | wral.com‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15%November 9, 2023 | fiercebiotech.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGKP, SEPL, KOS, and SQZ Company DescriptionsKosmos Energy NYSE:KOS$1.71 -0.01 (-0.58%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$1.70 0.00 (-0.29%) As of 04/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kosmos Energy Ltd., together with its subsidiaries, engages in the exploration, development, and production of oil and gas along the Atlantic Margins in the United States. The company's primary assets include production projects located in offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico, as well as gas projects located in offshore Mauritania and Senegal. It undertakes a proven basin exploration program in Equatorial Guinea and the U.S. Gulf of Mexico. Kosmos Energy Ltd. was founded in 2003 and is headquartered in Dallas, Texas.SQZ Biotechnologies NYSE:SQZ$0.04 +0.01 (+42.86%) As of 04/25/2025SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
